speb/financial-data huggingface dataset:
GMED balance_sheet (annual, 2025-12-31) — Common Stock: 135000.00
GMED balance_sheet (quarterly, 2025-12-31) — Common Stock: 135000.00
GMED balance_sheet (annual, 2025-12-31) — Common Stock Equity: 4573250000.00
GMED balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 4573250000.00
GMED cash_flow (annual, 2025-12-31) — Common Stock Payments: -300451000.00
GMED cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -45000000.00
GMED income_statement (annual, 2025-12-31) — Cost Of Revenue: 957802000.00
GMED income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 261107000.00
GMED balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 137241000.00
GMED balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 137241000.00
GMED balance_sheet (annual, 2025-12-31) — Current Assets: 2125611000.00
GMED balance_sheet (quarterly, 2025-12-31) — Current Assets: 2125611000.00
GMED balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 14738000.00
GMED balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 14738000.00
GMED balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 14738000.00
GMED balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 14738000.00
GMED balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 27655000.00
GMED balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 27655000.00
GMED balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 27655000.00
GMED balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 27655000.00
GMED balance_sheet (annual, 2025-12-31) — Current Liabilities: 498499000.00
GMED balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 498499000.00
GMED cash_flow (annual, 2025-12-31) — Deferred Income Tax: 18625000.00
GMED cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 18100000.00
GMED cash_flow (annual, 2025-12-31) — Deferred Tax: 18625000.00
GMED cash_flow (quarterly, 2025-12-31) — Deferred Tax: 18100000.00
GMED cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 276842000.00
GMED cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 69011000.00
GMED income_statement (annual, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 118194000.00
GMED income_statement (quarterly, 2025-12-31) — Depreciation Amortization Depletion Income Statement: 29360000.00
GMED cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 276842000.00
GMED cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 69011000.00
GMED income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 118194000.00
GMED income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 29360000.00
GMED income_statement (annual, 2025-12-31) — Diluted Average Shares: 137056000.00
GMED income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 136574000.00
GMED income_statement (annual, 2025-12-31) — Diluted EPS: 3.92
GMED income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.03
GMED income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 537868000.00
GMED income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 140594000.00
GMED income_statement (annual, 2025-12-31) — EBIT: 537191000.00
GMED income_statement (quarterly, 2025-12-31) — EBIT: 181310000.00
GMED income_statement (annual, 2025-12-31) — EBITDA: 814033000.00
GMED income_statement (quarterly, 2025-12-31) — EBITDA: 250321000.00
GMED cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 22445000.00
GMED cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 4034000.00
GMED cash_flow (annual, 2025-12-31) — End Cash Position: 526156000.00
GMED cash_flow (quarterly, 2025-12-31) — End Cash Position: 526156000.00
GMED cash_flow (annual, 2025-12-31) — Financing Cash Flow: -679160000.00
GMED cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 13215000.00
GMED balance_sheet (annual, 2025-12-31) — Finished Goods: 532568000.00
GMED balance_sheet (quarterly, 2025-12-31) — Finished Goods: 532568000.00
GMED cash_flow (annual, 2025-12-31) — Free Cash Flow: 579022000.00
GMED cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 202310000.00
GMED income_statement (annual, 2025-12-31) — Gain On Sale Of Security: -3006000.00
GMED income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: -7153000.00
GMED balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 15346000.00
GMED balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: 15346000.00
GMED balance_sheet (annual, 2025-12-31) — Goodwill: 1435033000.00
GMED balance_sheet (quarterly, 2025-12-31) — Goodwill: 1435033000.00
GMED balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 2180097000.00
GMED balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 2180097000.00
GMED balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 712372000.00
GMED balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 712372000.00
GMED balance_sheet (annual, 2025-12-31) — Gross PPE: 1333238000.00
GMED balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1333238000.00
GMED income_statement (annual, 2025-12-31) — Gross Profit: 1981129000.00
GMED income_statement (quarterly, 2025-12-31) — Gross Profit: 565313000.00
GMED balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 36855000.00
GMED balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 36855000.00
GMED cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 98916000.00
GMED cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 3820000.00
GMED balance_sheet (annual, 2025-12-31) — Income Tax Payable: 4155000.00
GMED balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 4155000.00
GMED balance_sheet (annual, 2025-12-31) — Inventory: 759277000.00
GMED balance_sheet (quarterly, 2025-12-31) — Inventory: 759277000.00
GMED balance_sheet (annual, 2025-12-31) — Invested Capital: 4573250000.00
GMED balance_sheet (quarterly, 2025-12-31) — Invested Capital: 4573250000.00
GMED cash_flow (annual, 2025-12-31) — Investing Cash Flow: -355014000.00
GMED cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -111449000.00
GMED balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 71819000.00
GMED balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 71819000.00
GMED balance_sheet (annual, 2025-12-31) — Investments And Advances: 71819000.00
GMED balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 71819000.00
GMED balance_sheet (annual, 2025-12-31) — Land And Improvements: 10849000.00
GMED balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 10849000.00
GMED balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 103918000.00
GMED balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 103918000.00
GMED balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 103918000.00
GMED balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 103918000.00
GMED cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -252546000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: 0.00
GMED cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -300451000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -45000000.00
GMED cash_flow (annual, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: -12591000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Foreign Currency Exchange Gain Loss: 2030000.00
GMED income_statement (annual, 2025-12-31) — Net Income: 537868000.00
GMED income_statement (quarterly, 2025-12-31) — Net Income: 140594000.00
GMED income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 537868000.00
GMED income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 140594000.00
GMED income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 537868000.00
GMED income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 140594000.00
GMED income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 537868000.00
GMED income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 140594000.00
GMED income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 537868000.00
GMED income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 140594000.00
GMED cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 537868000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 140594000.00
GMED income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 537868000.00
GMED income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 140594000.00
GMED cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -9746000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: -80000.00
GMED income_statement (annual, 2025-12-31) — Net Interest Income: 7141000.00
GMED income_statement (quarterly, 2025-12-31) — Net Interest Income: 3312000.00
GMED cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 71957000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -65172000.00
GMED cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -449985000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 0.00
GMED income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 7141000.00
GMED income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 3312000.00
GMED cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -18481000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -4543000.00
GMED balance_sheet (annual, 2025-12-31) — Net PPE: 628238000.00
GMED balance_sheet (quarterly, 2025-12-31) — Net PPE: 628238000.00
GMED cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -164679000.00
GMED cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -46197000.00
GMED cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: -449985000.00
GMED cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 0.00
GMED balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2393153000.00
GMED balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2393153000.00
GMED balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 218215000.00
GMED balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 218215000.00
GMED balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 23756000.00
GMED balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 23756000.00
GMED balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 218215000.00
GMED balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 218215000.00
GMED balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 23756000.00
GMED balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 23756000.00
GMED income_statement (annual, 2025-12-31) — Normalized EBITDA: 756710000.00
GMED income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 266101000.00
GMED income_statement (annual, 2025-12-31) — Normalized Income: 486907853.00
GMED income_statement (quarterly, 2025-12-31) — Normalized Income: 153703578.63
GMED cash_flow (annual, 2025-12-31) — Operating Cash Flow: 753447000.00
GMED cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 248587000.00
GMED cash_flow (annual, 2025-12-31) — Operating Gains Losses: -66000.00
GMED cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: 6117000.00
GMED income_statement (annual, 2025-12-31) — Operating Income: 537191000.00
GMED income_statement (quarterly, 2025-12-31) — Operating Income: 181310000.00
GMED income_statement (annual, 2025-12-31) — Operating Revenue: 2938931000.00
GMED income_statement (quarterly, 2025-12-31) — Operating Revenue: 826420000.00
GMED balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 112625126.00
GMED balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 112625126.00
GMED balance_sheet (annual, 2025-12-31) — Other Current Assets: 65426000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 65426000.00
GMED balance_sheet (annual, 2025-12-31) — Other Current Liabilities: 19513000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Current Liabilities: 19513000.00
GMED balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: 15346000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: 15346000.00
GMED income_statement (annual, 2025-12-31) — Other Income Expense: 60736000.00
GMED income_statement (quarterly, 2025-12-31) — Other Income Expense: -15389000.00
GMED balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 745064000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 745064000.00
GMED cash_flow (annual, 2025-12-31) — Other Non Cash Items: -95148000.00
GMED cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 13339000.00
GMED balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 78781000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 78781000.00
GMED balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 103338000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 103338000.00
GMED income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 3413000.00
GMED income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 391000.00
GMED balance_sheet (annual, 2025-12-31) — Other Properties: 1194816000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Properties: 1194816000.00
GMED balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 31087000.00
GMED balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 31087000.00
GMED balance_sheet (annual, 2025-12-31) — Payables: 132247000.00
GMED balance_sheet (quarterly, 2025-12-31) — Payables: 132247000.00
GMED balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 269488000.00
GMED balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 269488000.00
GMED balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 167105000.00
GMED balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 167105000.00
GMED income_statement (annual, 2025-12-31) — Pretax Income: 605068000.00
GMED income_statement (quarterly, 2025-12-31) — Pretax Income: 169233000.00
GMED cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 89757000.00
GMED cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 62758000.00
GMED balance_sheet (annual, 2025-12-31) — Properties: 0.00
GMED balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
GMED cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 32342000.00
GMED cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 11043000.00
GMED cash_flow (annual, 2025-12-31) — Purchase Of Business: -252546000.00
GMED cash_flow (quarterly, 2025-12-31) — Purchase Of Business: 0.00
GMED cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -9746000.00
GMED cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: -80000.00
GMED cash_flow (annual, 2025-12-31) — Purchase Of Investment: -107531000.00
GMED cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -70422000.00
GMED cash_flow (annual, 2025-12-31) — Purchase Of PPE: -164679000.00
GMED cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -46197000.00
GMED balance_sheet (annual, 2025-12-31) — Raw Materials: 162247000.00
GMED balance_sheet (quarterly, 2025-12-31) — Raw Materials: 162247000.00
GMED balance_sheet (annual, 2025-12-31) — Receivables: 743665000.00
GMED balance_sheet (quarterly, 2025-12-31) — Receivables: 743665000.00
GMED income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 799154000.00
GMED income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 221456000.00
GMED income_statement (annual, 2025-12-31) — Reconciled Depreciation: 276842000.00
GMED income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 69011000.00
GMED cash_flow (annual, 2025-12-31) — Repayment Of Debt: -449985000.00
GMED cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
GMED cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -300451000.00
GMED cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -45000000.00
GMED income_statement (annual, 2025-12-31) — Research And Development: 147246000.00
GMED income_statement (quarterly, 2025-12-31) — Research And Development: 36163000.00
GMED income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: -60329000.00
GMED income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: 8627000.00
GMED balance_sheet (annual, 2025-12-31) — Retained Earnings: 1387957000.00
GMED balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 1387957000.00
GMED cash_flow (annual, 2025-12-31) — Sale Of Investment: 179488000.00
GMED cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 5250000.00
GMED income_statement (annual, 2025-12-31) — Selling General And Administration: 1178498000.00
GMED income_statement (quarterly, 2025-12-31) — Selling General And Administration: 318480000.00
GMED balance_sheet (annual, 2025-12-31) — Share Issued: 112625126.00
GMED balance_sheet (quarterly, 2025-12-31) — Share Issued: 112625126.00
GMED cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -449985000.00
GMED cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: 0.00
GMED income_statement (annual, 2025-12-31) — Special Income Charges: 60329000.00
GMED income_statement (quarterly, 2025-12-31) — Special Income Charges: -8627000.00
GMED cash_flow (annual, 2025-12-31) — Stock Based Compensation: 49779000.00
GMED cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 11418000.00
GMED balance_sheet (annual, 2025-12-31) — Stockholders Equity: 4573250000.00
GMED balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 4573250000.00
GMED balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2393153000.00
GMED balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2393153000.00
GMED income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 6362853.00
GMED income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -2670421.37
GMED income_statement (annual, 2025-12-31) — Tax Provision: 67200000.00
GMED income_statement (quarterly, 2025-12-31) — Tax Provision: 28639000.00
GMED income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.11
GMED income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.17
GMED balance_sheet (annual, 2025-12-31) — Taxes Receivable: 64727000.00
GMED balance_sheet (quarterly, 2025-12-31) — Taxes Receivable: 64727000.00
GMED balance_sheet (annual, 2025-12-31) — Total Assets: 5302761000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Assets: 5302761000.00
GMED balance_sheet (annual, 2025-12-31) — Total Capitalization: 4573250000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 4573250000.00
GMED balance_sheet (annual, 2025-12-31) — Total Debt: 118656000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Debt: 118656000.00
GMED balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 4573250000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 4573250000.00
GMED income_statement (annual, 2025-12-31) — Total Expenses: 2401740000.00
GMED income_statement (quarterly, 2025-12-31) — Total Expenses: 645110000.00
GMED balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 729511000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 729511000.00
GMED balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 3177150000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 3177150000.00
GMED balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 231012000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 231012000.00
GMED income_statement (annual, 2025-12-31) — Total Operating Income As Reported: 479816000.00
GMED income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: 169340000.00
GMED income_statement (annual, 2025-12-31) — Total Other Finance Cost: -7141000.00
GMED income_statement (quarterly, 2025-12-31) — Total Other Finance Cost: -3312000.00
GMED balance_sheet (annual, 2025-12-31) — Total Tax Payable: 33395000.00
GMED balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 33395000.00
GMED income_statement (annual, 2025-12-31) — Total Unusual Items: 57323000.00
GMED income_statement (quarterly, 2025-12-31) — Total Unusual Items: -15780000.00
GMED income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 57323000.00
GMED income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -15780000.00
GMED balance_sheet (annual, 2025-12-31) — Work In Process: 64462000.00
GMED balance_sheet (quarterly, 2025-12-31) — Work In Process: 64462000.00
GMED balance_sheet (annual, 2025-12-31) — Working Capital: 1627112000.00
GMED balance_sheet (quarterly, 2025-12-31) — Working Capital: 1627112000.00
GMED income_statement (quarterly, 2026-03-31) — +Operating Expense: 363811000.00
GMED income_statement (quarterly, 2026-03-31) — +Total Revenue: 759854000.00
GMED balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 103658000.00
GMED balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 686433000.00
GMED balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -747582000.00
GMED balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 3205514000.00
GMED balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -40933000.00
GMED income_statement (quarterly, 2026-03-31) — Amortization: 29526000.00
GMED income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 29526000.00
GMED balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 89435000.00
GMED income_statement (quarterly, 2026-03-31) — Basic Average Shares: 135364000.00
GMED income_statement (quarterly, 2026-03-31) — Basic EPS: 0.92
GMED cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 526156000.00
GMED balance_sheet (quarterly, 2026-03-31) — Buildings And Improvements: 127833000.00
GMED cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -39615000.00
GMED balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 115223000.00
GMED balance_sheet (quarterly, 2026-03-31) — Capital Stock: 135000.00
GMED balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 560950000.00
GMED balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 629851000.00
GMED cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 18197000.00
GMED cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -182674000.00
GMED cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 202364000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Account Payable: 5082000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Accrued Expense: -24668000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Inventory: -16651000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Other Working Capital: 14576000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Payable: 5082000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -19586000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: 6942000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Receivables: -13399000.00
GMED cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -28118000.00
GMED cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -13399000.00
GMED cash_flow (quarterly, 2026-03-31) — Changes In Cash: 37887000.00
GMED balance_sheet (quarterly, 2026-03-31) — Common Stock: 135000.00
GMED balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 4732312000.00
GMED cash_flow (quarterly, 2026-03-31) — Common Stock Payments: 0.00
GMED income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 234066000.00
GMED balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 137991000.00
GMED balance_sheet (quarterly, 2026-03-31) — Current Assets: 2198120000.00
GMED balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 15121000.00
GMED balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 15121000.00
GMED balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 26347000.00
GMED balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 26347000.00
GMED balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 482463000.00
GMED cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 7962000.00
GMED cash_flow (quarterly, 2026-03-31) — Deferred Tax: 7962000.00
GMED cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 69856000.00
GMED income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 29526000.00
GMED cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 69856000.00
GMED income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 29526000.00
GMED income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 138191000.00
GMED income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.90
GMED income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 124302000.00
GMED income_statement (quarterly, 2026-03-31) — EBIT: 161977000.00
GMED income_statement (quarterly, 2026-03-31) — EBITDA: 231833000.00
GMED cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -3093000.00
GMED cash_flow (quarterly, 2026-03-31) — End Cash Position: 560950000.00
GMED cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 18197000.00
GMED balance_sheet (quarterly, 2026-03-31) — Finished Goods: 539084000.00
GMED cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 162749000.00
GMED income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -2113000.00
GMED balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: 14404000.00
GMED balance_sheet (quarterly, 2026-03-31) — Goodwill: 1438733000.00
GMED balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 2159578000.00
GMED balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 727366000.00
GMED balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1366228000.00
GMED income_statement (quarterly, 2026-03-31) — Gross Profit: 525788000.00
GMED balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 80002000.00
GMED cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 5991000.00
GMED balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 3032000.00
GMED balance_sheet (quarterly, 2026-03-31) — Inventory: 772602000.00
GMED balance_sheet (quarterly, 2026-03-31) — Invested Capital: 4732312000.00
GMED cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -182674000.00
GMED balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 169437000.00
GMED balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 169437000.00
GMED balance_sheet (quarterly, 2026-03-31) — Land And Improvements: 10830000.00
GMED balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 100102000.00
GMED balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 100102000.00
GMED cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: 0.00
GMED cash_flow (quarterly, 2026-03-31) — Net Business Purchase And Sale: -4909000.00
GMED cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 0.00
GMED cash_flow (quarterly, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 98000.00
GMED income_statement (quarterly, 2026-03-31) — Net Income: 124302000.00
GMED income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 124302000.00
GMED income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 124302000.00
GMED income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 124302000.00
GMED income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 124302000.00
GMED cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 124302000.00
GMED income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 124302000.00
GMED income_statement (quarterly, 2026-03-31) — Net Interest Income: 5434000.00
GMED cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -138150000.00
GMED cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 0.00
GMED cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 0.00
GMED income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 5434000.00
GMED cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -7764000.00
GMED balance_sheet (quarterly, 2026-03-31) — Net PPE: 618646000.00
GMED cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -39615000.00
GMED balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 2572734000.00
GMED balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 214810000.00
GMED balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 24658000.00
GMED balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 214810000.00
GMED balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 24658000.00
GMED income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 244417000.00
GMED income_statement (quarterly, 2026-03-31) — Normalized Income: 134255944.00
GMED cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 202364000.00
GMED cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 2547000.00
GMED income_statement (quarterly, 2026-03-31) — Operating Income: 161977000.00
GMED income_statement (quarterly, 2026-03-31) — Operating Revenue: 759854000.00
GMED balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 135666196.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 60228000.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 20874000.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: 14404000.00
GMED income_statement (quarterly, 2026-03-31) — Other Income Expense: -10337000.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 720845000.00
GMED cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2961000.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 78964000.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 100020000.00
GMED income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 2247000.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Properties: 1227565000.00
GMED balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 68901000.00
GMED balance_sheet (quarterly, 2026-03-31) — Payables: 135828000.00
GMED balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 273819000.00
GMED balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 146302000.00
GMED income_statement (quarterly, 2026-03-31) — Pretax Income: 157074000.00
GMED cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 25961000.00
GMED balance_sheet (quarterly, 2026-03-31) — Properties: 0.00
GMED cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: 10237000.00
GMED cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -4909000.00
GMED cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -146393000.00
GMED cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -39615000.00
GMED balance_sheet (quarterly, 2026-03-31) — Raw Materials: 163831000.00
GMED balance_sheet (quarterly, 2026-03-31) — Receivables: 735439000.00
GMED income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 193736000.00
GMED income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 69856000.00
GMED cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: 0.00
GMED cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: 0.00
GMED income_statement (quarterly, 2026-03-31) — Research And Development: 36510000.00
GMED income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 10471000.00
GMED balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 1512259000.00
GMED cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 8243000.00
GMED income_statement (quarterly, 2026-03-31) — Selling General And Administration: 297775000.00
GMED balance_sheet (quarterly, 2026-03-31) — Share Issued: 135666196.00
GMED income_statement (quarterly, 2026-03-31) — Special Income Charges: -10471000.00
GMED cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 12617000.00
GMED balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4732312000.00
GMED balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 2572734000.00
GMED income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -2630056.00
GMED income_statement (quarterly, 2026-03-31) — Tax Provision: 32772000.00
GMED income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.21
GMED balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 49006000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Assets: 5439555000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 4732312000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Debt: 115223000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 4732312000.00
GMED income_statement (quarterly, 2026-03-31) — Total Expenses: 597877000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 707243000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3241435000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 224780000.00
GMED income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 150388000.00
GMED income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -5434000.00
GMED balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 32170000.00
GMED income_statement (quarterly, 2026-03-31) — Total Unusual Items: -12584000.00
GMED income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -12584000.00
GMED balance_sheet (quarterly, 2026-03-31) — Work In Process: 69687000.00
GMED balance_sheet (quarterly, 2026-03-31) — Working Capital: 1715657000.00
GMET.L balance_sheet (annual, 2022-06-30) — Accounts Payable: 150000.00
GMET.L balance_sheet (annual, 2022-06-30) — Additional Paid In Capital: 4126000.00
GMET.L balance_sheet (annual, 2022-06-30) — Capital Stock: 728000.00
GMET.L balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 40000.00
GMET.L balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 40000.00
GMET.L balance_sheet (annual, 2022-06-30) — Common Stock: 728000.00
GMET.L balance_sheet (annual, 2022-06-30) — Common Stock Equity: 7299000.00
GMET.L balance_sheet (annual, 2022-06-30) — Current Assets: 209000.00
GMET.L balance_sheet (annual, 2022-06-30) — Current Liabilities: 150000.00
GMET.L balance_sheet (annual, 2022-06-30) — Goodwill And Other Intangible Assets: 7240000.00
GMET.L balance_sheet (annual, 2022-06-30) — Gross PPE: 7240000.00
GMET.L balance_sheet (annual, 2022-06-30) — Invested Capital: 7299000.00
GMET.L balance_sheet (annual, 2022-06-30) — Net PPE: 7240000.00
GMET.L balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 7299000.00
GMET.L balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 84194373.00
GMET.L balance_sheet (annual, 2022-06-30) — Other Intangible Assets: 7240000.00
GMET.L balance_sheet (annual, 2022-06-30) — Other Receivables: 80000.00
GMET.L balance_sheet (annual, 2022-06-30) — Payables: 150000.00
GMET.L balance_sheet (annual, 2022-06-30) — Properties: 7240000.00
GMET.L balance_sheet (annual, 2022-06-30) — Retained Earnings: -3506000.00
GMET.L balance_sheet (annual, 2022-06-30) — Share Issued: 84194373.00
GMET.L balance_sheet (annual, 2022-06-30) — Stockholders Equity: 7299000.00
GMET.L balance_sheet (annual, 2022-06-30) — Tangible Book Value: 7299000.00
GMET.L balance_sheet (annual, 2022-06-30) — Taxes Receivable: 89000.00
GMET.L balance_sheet (annual, 2022-06-30) — Total Assets: 7449000.00
GMET.L balance_sheet (annual, 2022-06-30) — Total Capitalization: 7299000.00
GMET.L balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 7299000.00
GMET.L balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 150000.00
GMET.L balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 7240000.00
GMET.L balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
GMET.L balance_sheet (annual, 2022-06-30) — Working Capital: 59000.00
GMET.L income_statement (annual, 2023-06-30) — +Operating Expense: 878000.00
GMET.L income_statement (annual, 2023-06-30) — +Total Revenue: 30000.00
GMET.L balance_sheet (annual, 2023-06-30) — Accounts Payable: 139000.00
GMET.L balance_sheet (annual, 2023-06-30) — Accumulated Depreciation: 0.00
GMET.L balance_sheet (annual, 2023-06-30) — Additional Paid In Capital: 6195000.00
GMET.L income_statement (annual, 2023-06-30) — Basic Average Shares: 63422112.00
GMET.L income_statement (annual, 2023-06-30) — Basic EPS: -0.01
GMET.L cash_flow (annual, 2023-06-30) — Beginning Cash Position: 40000.00
GMET.L cash_flow (annual, 2023-06-30) — Capital Expenditure: -374000.00
GMET.L balance_sheet (annual, 2023-06-30) — Capital Stock: 1043000.00
GMET.L balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 1371000.00
GMET.L balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 1371000.00
GMET.L balance_sheet (annual, 2023-06-30) — Cash Financial: 1371000.00
GMET.L cash_flow (annual, 2023-06-30) — Change In Payable: 511000.00
GMET.L cash_flow (annual, 2023-06-30) — Change In Receivables: -128000.00
GMET.L cash_flow (annual, 2023-06-30) — Change In Working Capital: 383000.00
GMET.L cash_flow (annual, 2023-06-30) — Changes In Cash: 1329000.00
GMET.L balance_sheet (annual, 2023-06-30) — Common Stock: 1043000.00
GMET.L balance_sheet (annual, 2023-06-30) — Common Stock Equity: 9039000.00
GMET.L cash_flow (annual, 2023-06-30) — Common Stock Issuance: 2160000.00
GMET.L balance_sheet (annual, 2023-06-30) — Current Assets: 1657000.00
GMET.L balance_sheet (annual, 2023-06-30) — Current Liabilities: 414000.00
GMET.L income_statement (annual, 2023-06-30) — Diluted Average Shares: 63422112.00
GMET.L income_statement (annual, 2023-06-30) — Diluted EPS: -0.01
GMET.L income_statement (annual, 2023-06-30) — Diluted NI Availto Com Stockholders: -848000.00
GMET.L income_statement (annual, 2023-06-30) — EBIT: -848000.00
GMET.L income_statement (annual, 2023-06-30) — EBITDA: -848000.00
GMET.L cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: 2000.00
GMET.L cash_flow (annual, 2023-06-30) — End Cash Position: 1371000.00
GMET.L cash_flow (annual, 2023-06-30) — Financing Cash Flow: 1864000.00
GMET.L cash_flow (annual, 2023-06-30) — Free Cash Flow: -535000.00
GMET.L income_statement (annual, 2023-06-30) — General And Administrative Expense: 589000.00
GMET.L balance_sheet (annual, 2023-06-30) — Goodwill And Other Intangible Assets: 7796000.00
GMET.L balance_sheet (annual, 2023-06-30) — Gross PPE: 7796000.00
GMET.L balance_sheet (annual, 2023-06-30) — Invested Capital: 9039000.00
GMET.L cash_flow (annual, 2023-06-30) — Investing Cash Flow: -374000.00
GMET.L cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 2160000.00
GMET.L cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 2160000.00
GMET.L cash_flow (annual, 2023-06-30) — Net Foreign Currency Exchange Gain Loss: -14000.00
GMET.L income_statement (annual, 2023-06-30) — Net Income: -848000.00
GMET.L income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -848000.00
GMET.L income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -848000.00
GMET.L income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -848000.00
GMET.L income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -848000.00
GMET.L cash_flow (annual, 2023-06-30) — Net Income From Continuing Operations: -848000.00
GMET.L income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -848000.00
GMET.L cash_flow (annual, 2023-06-30) — Net Intangibles Purchase And Sale: -374000.00
GMET.L balance_sheet (annual, 2023-06-30) — Net PPE: 7796000.00
GMET.L balance_sheet (annual, 2023-06-30) — Net Tangible Assets: 9039000.00
GMET.L income_statement (annual, 2023-06-30) — Normalized EBITDA: -848000.00
GMET.L income_statement (annual, 2023-06-30) — Normalized Income: -848000.00
GMET.L cash_flow (annual, 2023-06-30) — Operating Cash Flow: -161000.00
GMET.L income_statement (annual, 2023-06-30) — Operating Income: -848000.00
GMET.L income_statement (annual, 2023-06-30) — Operating Revenue: 30000.00
GMET.L balance_sheet (annual, 2023-06-30) — Ordinary Shares Number: 85000255.00
GMET.L balance_sheet (annual, 2023-06-30) — Other Equity Interest: 51000.00
GMET.L balance_sheet (annual, 2023-06-30) — Other Intangible Assets: 7796000.00
GMET.L balance_sheet (annual, 2023-06-30) — Other Payable: 59000.00
GMET.L balance_sheet (annual, 2023-06-30) — Other Receivables: 237000.00
GMET.L income_statement (annual, 2023-06-30) — Otherunder Preferred Stock Dividend: 0.00
GMET.L balance_sheet (annual, 2023-06-30) — Payables: 198000.00
GMET.L income_statement (annual, 2023-06-30) — Pretax Income: -848000.00
GMET.L balance_sheet (annual, 2023-06-30) — Properties: 7796000.00
GMET.L cash_flow (annual, 2023-06-30) — Purchase Of Intangibles: -374000.00
GMET.L balance_sheet (annual, 2023-06-30) — Retained Earnings: -4354000.00
GMET.L income_statement (annual, 2023-06-30) — Selling General And Administration: 589000.00
GMET.L balance_sheet (annual, 2023-06-30) — Share Issued: 85000255.00
GMET.L cash_flow (annual, 2023-06-30) — Stock Based Compensation: 318000.00
GMET.L balance_sheet (annual, 2023-06-30) — Stockholders Equity: 9039000.00
GMET.L balance_sheet (annual, 2023-06-30) — Tangible Book Value: 9039000.00
GMET.L income_statement (annual, 2023-06-30) — Tax Effect Of Unusual Items: 0.00
GMET.L income_statement (annual, 2023-06-30) — Tax Provision: 0.00
GMET.L income_statement (annual, 2023-06-30) — Tax Rate For Calcs: 0.00
GMET.L balance_sheet (annual, 2023-06-30) — Taxes Receivable: 49000.00
GMET.L balance_sheet (annual, 2023-06-30) — Total Assets: 9453000.00
GMET.L balance_sheet (annual, 2023-06-30) — Total Capitalization: 9039000.00
GMET.L balance_sheet (annual, 2023-06-30) — Total Equity Gross Minority Interest: 9039000.00
GMET.L income_statement (annual, 2023-06-30) — Total Expenses: 878000.00
GMET.L balance_sheet (annual, 2023-06-30) — Total Liabilities Net Minority Interest: 414000.00
GMET.L balance_sheet (annual, 2023-06-30) — Total Non Current Assets: 7796000.00
GMET.L balance_sheet (annual, 2023-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
GMET.L income_statement (annual, 2023-06-30) — Total Operating Income As Reported: -848000.00
GMET.L balance_sheet (annual, 2023-06-30) — Treasury Shares Number: 0.00
GMET.L balance_sheet (annual, 2023-06-30) — Working Capital: 1243000.00
GMET.L income_statement (annual, 2024-06-30) — +Operating Expense: 1376000.00
GMET.L income_statement (annual, 2024-06-30) — +Total Revenue: 0.00
GMET.L balance_sheet (annual, 2024-06-30) — Accounts Payable: 251000.00
GMET.L balance_sheet (annual, 2024-06-30) — Accumulated Depreciation: 0.00
GMET.L balance_sheet (annual, 2024-06-30) — Additional Paid In Capital: 9680000.00
GMET.L income_statement (annual, 2024-06-30) — Basic Average Shares: 89803058.00
GMET.L income_statement (annual, 2024-06-30) — Basic EPS: -0.02
GMET.L cash_flow (annual, 2024-06-30) — Beginning Cash Position: 1371000.00
GMET.L cash_flow (annual, 2024-06-30) — Capital Expenditure: -1496000.00
GMET.L balance_sheet (annual, 2024-06-30) — Capital Stock: 1346000.00
GMET.L balance_sheet (annual, 2024-06-30) — Cash And Cash Equivalents: 3033000.00
GMET.L balance_sheet (annual, 2024-06-30) — Cash Cash Equivalents And Short Term Investments: 3033000.00
GMET.L balance_sheet (annual, 2024-06-30) — Cash Financial: 3033000.00
GMET.L cash_flow (annual, 2024-06-30) — Change In Payable: 415000.00
GMET.L cash_flow (annual, 2024-06-30) — Change In Receivables: 53000.00
GMET.L cash_flow (annual, 2024-06-30) — Change In Working Capital: 468000.00
GMET.L cash_flow (annual, 2024-06-30) — Changes In Cash: 1665000.00
GMET.L balance_sheet (annual, 2024-06-30) — Common Stock: 1346000.00
GMET.L balance_sheet (annual, 2024-06-30) — Common Stock Equity: 11723000.00
GMET.L cash_flow (annual, 2024-06-30) — Common Stock Issuance: 3876000.00
GMET.L balance_sheet (annual, 2024-06-30) — Current Assets: 3269000.00
GMET.L balance_sheet (annual, 2024-06-30) — Current Liabilities: 826000.00
GMET.L income_statement (annual, 2024-06-30) — Diluted Average Shares: 89803058.00
GMET.L income_statement (annual, 2024-06-30) — Diluted EPS: -0.02
GMET.L income_statement (annual, 2024-06-30) — Diluted NI Availto Com Stockholders: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — EBIT: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — EBITDA: -1376000.00
GMET.L cash_flow (annual, 2024-06-30) — Effect Of Exchange Rate Changes: -3000.00
GMET.L cash_flow (annual, 2024-06-30) — End Cash Position: 3033000.00
GMET.L cash_flow (annual, 2024-06-30) — Financing Cash Flow: 3819000.00
GMET.L cash_flow (annual, 2024-06-30) — Free Cash Flow: -2154000.00
GMET.L income_statement (annual, 2024-06-30) — General And Administrative Expense: 898000.00
GMET.L balance_sheet (annual, 2024-06-30) — Gross PPE: 9280000.00
GMET.L income_statement (annual, 2024-06-30) — Interest Income: 0.00
GMET.L income_statement (annual, 2024-06-30) — Interest Income Non Operating: 0.00
GMET.L balance_sheet (annual, 2024-06-30) — Invested Capital: 11723000.00
GMET.L cash_flow (annual, 2024-06-30) — Investing Cash Flow: -1496000.00
GMET.L cash_flow (annual, 2024-06-30) — Issuance Of Capital Stock: 3876000.00
GMET.L cash_flow (annual, 2024-06-30) — Net Common Stock Issuance: 3876000.00
GMET.L cash_flow (annual, 2024-06-30) — Net Foreign Currency Exchange Gain Loss: -3000.00
GMET.L income_statement (annual, 2024-06-30) — Net Income: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — Net Income Common Stockholders: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — Net Income Continuous Operations: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — Net Income From Continuing And Discontinued Operation: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — Net Income From Continuing Operation Net Minority Interest: -1376000.00
GMET.L cash_flow (annual, 2024-06-30) — Net Income From Continuing Operations: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — Net Income Including Noncontrolling Interests: -1376000.00
GMET.L cash_flow (annual, 2024-06-30) — Net Intangibles Purchase And Sale: -1496000.00
GMET.L income_statement (annual, 2024-06-30) — Net Interest Income: 0.00
GMET.L income_statement (annual, 2024-06-30) — Net Non Operating Interest Income Expense: 0.00
GMET.L balance_sheet (annual, 2024-06-30) — Net PPE: 9280000.00
GMET.L balance_sheet (annual, 2024-06-30) — Net Tangible Assets: 11723000.00
GMET.L income_statement (annual, 2024-06-30) — Normalized EBITDA: -1376000.00
GMET.L income_statement (annual, 2024-06-30) — Normalized Income: -1376000.00
GMET.L cash_flow (annual, 2024-06-30) — Operating Cash Flow: -658000.00